NCT03452501 2021-02-23Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsHikma Pharmaceuticals LLCCompleted157 enrolled
NCT00724672 2015-06-01A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)Merck Sharp & Dohme LLCWithdrawn